A phase 3, randomized study to evaluate the safety, tolerability, and immunogenicity of V116 in children and adolescents with increased risk of pneumococcal disease (STRIDE-13)

Vinita Jagannath, Jayani Pathirana, Carlos Alberto Perez Yepes, Eduardo Lopez-Medina, Juan Andres Navarro, Piotr Korbal, Wanatpreeya Phongsamart, Ayano Inui, Anu Kantele, Jibran E. Atwi, Bruce Tapiero, Derya Alabaz, Fernando Baquero-Artigao, Tiantian Zeng, Danielle Euler, Melanie Papa, Doreen Fernsler, Jun Park, Alejandra Esteves-Jaramillo, Heather L. Platt, Unknown

Open source

DOI
10.1080/21645515.2026.2684089
Published
2026-06-23
Container
Human Vaccines & Immunotherapeutics
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/21645515.2026.2684089,
  title = {A phase 3, randomized study to evaluate the safety, tolerability, and immunogenicity of V116 in children and adolescents with increased risk of pneumococcal disease (STRIDE-13)},
  author = {Vinita Jagannath and Jayani Pathirana and Carlos Alberto Perez Yepes and Eduardo Lopez-Medina and Juan Andres Navarro and Piotr Korbal and Wanatpreeya Phongsamart and Ayano Inui and Anu Kantele and Jibran E. Atwi and Bruce Tapiero and Derya Alabaz and Fernando Baquero-Artigao and Tiantian Zeng and Danielle Euler and Melanie Papa and Doreen Fernsler and Jun Park and Alejandra Esteves-Jaramillo and Heather L. Platt and Unknown},
  year = {2026},
  journal = {Human Vaccines \& Immunotherapeutics},
  doi = {10.1080/21645515.2026.2684089},
  url = {https://doi.org/10.1080/21645515.2026.2684089}
}

RIS

TY  - JOUR
TI  - A phase 3, randomized study to evaluate the safety, tolerability, and immunogenicity of V116 in children and adolescents with increased risk of pneumococcal disease (STRIDE-13)
AU  - Vinita Jagannath
AU  - Jayani Pathirana
AU  - Carlos Alberto Perez Yepes
AU  - Eduardo Lopez-Medina
AU  - Juan Andres Navarro
AU  - Piotr Korbal
AU  - Wanatpreeya Phongsamart
AU  - Ayano Inui
AU  - Anu Kantele
AU  - Jibran E. Atwi
AU  - Bruce Tapiero
AU  - Derya Alabaz
AU  - Fernando Baquero-Artigao
AU  - Tiantian Zeng
AU  - Danielle Euler
AU  - Melanie Papa
AU  - Doreen Fernsler
AU  - Jun Park
AU  - Alejandra Esteves-Jaramillo
AU  - Heather L. Platt
AU  - Unknown
PY  - 2026
JO  - Human Vaccines & Immunotherapeutics
DO  - 10.1080/21645515.2026.2684089
UR  - https://doi.org/10.1080/21645515.2026.2684089
ER  - 

APA

Jagannath, V., Pathirana, J., Yepes, C. A. P., Lopez-Medina, E., Navarro, J. A., Korbal, P., Phongsamart, W., Inui, A., Kantele, A., Atwi, J. E., Tapiero, B., Alabaz, D., Baquero-Artigao, F., Zeng, T., Euler, D., Papa, M., Fernsler, D., Park, J., Esteves-Jaramillo, A., Platt, H. L., & Unknown (2026). A phase 3, randomized study to evaluate the safety, tolerability, and immunogenicity of V116 in children and adolescents with increased risk of pneumococcal disease (STRIDE-13). Human Vaccines & Immunotherapeutics. https://doi.org/10.1080/21645515.2026.2684089

Source records